Personalized Ex Vivo Drug Screening and Genomics Profiling to Guide Individualized Treatments for Children with Relapsed or Refractory Solid Tumors and Leukemias Grant

Personalized Ex Vivo Drug Screening and Genomics Profiling to Guide Individualized Treatments for Children with Relapsed or Refractory Solid Tumors and Leukemias .

date/time interval

  • May 11, 2018 - October 31, 2022

awarded by

administered by

sponsor award ID

  • 8LA05

contributor